Skip to content
GLP-1 Clinics Nearby

Search the verified directory

For ClinicsClaim or manage your listing
GLP-1 Clinics Nearby
Brand comparisonAugust 2, 2026 · 7 min read

Ozempic vs. Wegovy: one molecule, two approvals

In short: Ozempic and Wegovy are the same active ingredient from the same manufacturer, approved for different things. If weight is the reason for treatment, Wegovy is usually the product being looked for.

Edited by

· Co-founder & CTO, Savo Group

B.S. in Computer Science, Oregon State University · B.A. in Psychology, University of Washington, Seattle

Clinician discussing semaglutide brand options with a patient during a weight-care appointment

Current status

FDA-approved products

Both are approved prescription products with different labels. Use current prescribing information and a qualified prescriber for product-specific decisions.

Shared ingredient
Semaglutide
Ozempic approved for
Type 2 diabetes
Wegovy approved for
Weight management
At a glance

Ozempic vs. Wegovy at product level

Same molecule, same manufacturer. The approved use is what separates them and what an insurer reads.

Swipe horizontally to compare →

Ozempic vs. Wegovy at product level. Same molecule, same manufacturer. The approved use is what separates them and what an insurer reads.
Product detailOzempicWegovy
Active ingredientSemaglutideSemaglutide
Receptor actionGLP-1GLP-1
FDA-approved useType 2 diabetesChronic weight management
Cardiovascular indicationRisk reduction in type 2 diabetes with established cardiovascular diseaseRisk reduction in adults with cardiovascular disease and overweight or obesity
Prescribed for weightOff-labelOn-label

Table source:FDA product prescribing information

01

Ozempic and Wegovy are the same medicine

Both products contain semaglutide and come from the same manufacturer. Neither is a stronger or weaker version of the other in any meaningful sense; they are two approvals of one molecule, prepared at different dose ranges for different populations.

So the question is not which one works better. It is which one your prescription should name, and that is decided by why you are being treated.

02

Why the label decides the price you pay

Ozempic is approved for type 2 diabetes. Wegovy is approved for chronic weight management in eligible adults, and both carry cardiovascular indications for different populations.

Prescribing Ozempic for weight loss is off-label. It is lawful, it is extremely common, and it is the single most frequent reason a plan declines to pay. Where weight is the reason for treatment and coverage matters, asking whether the clinic will write for Wegovy instead is often the most useful question of the first appointment.

  • Type 2 diabetes: Ozempic is the on-label product.
  • Weight management without a diabetes diagnosis: Wegovy is the on-label product.
  • Established cardiovascular disease: both carry an indication, for different populations. It is worth raising either way.
Neither indication is a statement about which product produces more weight loss. It describes what was submitted, reviewed and approved, which is what an insurer is reading when it answers a prior authorization.

03

The third option nobody advertises clearly

Most online programs advertising semaglutide at a low monthly price are dispensing neither Ozempic nor Wegovy. They are dispensing a compounded preparation, which is mixed by a pharmacy rather than manufactured and reviewed as a finished product.

That is a different regulatory category, not a generic version, and insurance almost never reimburses it. A cheaper monthly price can still produce a more expensive year.

Common questions

Answers to clarify the comparison

Is Wegovy just a higher dose of Ozempic?
Both contain semaglutide, and the approved dose ranges differ, but the meaningful difference is the approved use. Ozempic is approved for type 2 diabetes and Wegovy for chronic weight management, which is what decides how a prescription is written and whether a plan pays.
Why did my insurance cover Ozempic but not for weight loss?
Because prescribing Ozempic for weight is off-label. Plans commonly authorize it for the approved diabetes indication and decline the same medication when the diagnosis on the claim is obesity. Wegovy is the product approved for that use.
Which should I ask for?
If weight management is the reason for treatment and you do not have type 2 diabetes, Wegovy is the on-label product and usually the easier authorization. The prescriber decides, but it is worth raising at the first visit rather than after a refusal.

Primary sources

Read the official material behind this page

Health information is educational and does not diagnose, determine eligibility, or replace product labeling and care from a qualified professional.